GlobeNewswire Inc.··Radiopharm TheranosticsRadiopharm Theranostics Advances Pipeline as Cash Dwindles to $19.2M
Radiopharm completes Phase 2b enrollment for brain imaging agent RAD 101 with 90% MRI concordance, initiates new trials while cash reserves fall sharply.
RADXclinical trialsradiopharmaceuticals